[1]王燕,张兆辉,陈阳.大鼠局灶性脑缺血再灌注后LPA1的表达对神经元凋亡的影响[J].卒中与神经疾病杂志,2018,25(05):504-509.[doi:10.3969/j.issn.1007-0478.2018.05.004]
 Wang Yan*,Zhang Zhaohui,Chen Yang..The effects of LPA1 expression level on neuron apoptosis in rats after focal cerebral ischemia and reperfusion[J].Stroke and Nervous Diseases,2018,25(05):504-509.[doi:10.3969/j.issn.1007-0478.2018.05.004]
点击复制

大鼠局灶性脑缺血再灌注后LPA1的表达对神经元凋亡的影响()
分享到:

《卒中与神经疾病》杂志[ISSN:1007-0478/CN:42-1402/R]

卷:
第25卷
期数:
2018年05期
页码:
504-509
栏目:
论 著
出版日期:
2018-10-26

文章信息/Info

Title:
The effects of LPA1 expression level on neuron apoptosis in rats after focal cerebral ischemia and reperfusion
文章编号:
1007-0478(2018)05-0504-06
作者:
王燕张兆辉陈阳
476000 河南省商丘市第一人民医院神经内二科(王燕); 武汉大学人民医院神经内一科[张兆辉(通信作者)]; 内蒙古国际蒙医医院神经内科(陈阳)
Author(s):
Wang Yan*Zhang ZhaohuiChen Yang.
*Department of Neurology,The People's Hospital of Shangqiu City,Shangqiu Henan 476000
关键词:
溶血磷脂酸 溶血磷脂酸受体1 局灶性脑缺血再灌 脑梗死 神经元
Keywords:
Lysophosphatidic acid Lysophosphatidic acid receptor 1 Focal cerebral infarction and reperfusion Infarction Neurons
分类号:
R743.33
DOI:
10.3969/j.issn.1007-0478.2018.05.004
文献标志码:
A
摘要:
目的 探讨大鼠局灶性脑缺血再灌注后溶血磷脂酸受体1(LPA1)的表达对神经元凋亡的影响及其可能机制。方法 将24只SPF级SD雄性大鼠随机分为4组,每组各6只,分别为假手术组(A组)、大脑中动脉栓塞(MCAO)组(B组)、MCAO+溶剂组(C组)、MCAO+LPA1拮抗剂(Ki16425)组(D组); 4组均于手术后48 h取标本; 利用HE染色观察大鼠脑组织细胞形态的变化; 四氮唑红(TTC)染色观察大鼠脑梗死面积; 免疫荧光技术检测LPA1在大鼠皮层半暗带神经元表达水平; 免疫印迹、免疫组化技术检测大鼠脑组织中Caspase-3蛋白及p-Akt蛋白表达水平。结果 与A组比较,B组有明显的缺血再灌注损伤,表现为细胞肿胀,细胞溶解坏死,大鼠皮层半暗带神经元的LPA1表达水平较高; 与C组比较,D组大鼠脑梗死面积显著增大(P<0.05),缺血半暗带细胞肿胀更加明显,胞浆空泡区增大,细胞核固缩更加严重,细胞间隙增宽更明显; D组较C组缺血半暗带Caspase-3蛋白表达水平明显升高(P<0.05),而p-Akt蛋白表达水平明显降低(P<0.05)。结论 抑制大鼠局灶性脑缺血再灌后LPA1的表达可使大鼠脑梗死面积增大,细胞凋亡增加,同时p-Akt蛋白表达减少,这说明在大鼠局灶性缺血再灌注过程中LPA1对神经元具有保护作用,其机制可能是通过Akt途径来发挥保护作用的。
Abstract:
ObjectiveTo explore the effects of LPA1 expression level on cortical neuron apoptosis in ischemic penumbra after focal cerebral ischemia and reperfusion in rats and its possible mechanism.Methods 24 SD rats were randomly divided into four groups,namely,the sham group(group A),the right middle cerebral artery occlusion(MCAO)group(group B),MCAO +vehicle group(group C),MCAO+LPA1 antagonist(Ki16425)group(group D).All rats in four groups were taken brain tissue at the second day after surgery,the morphological changes of rats were measured by using H&E staining; the infarction area was measured by TTC staining; LPA1 expression level in neurons was located by immunofluorescence of Nuen and LPA1; the expression levels of caspase-3 and p-Akt were detected by Western blotting and immunohistochemical technology.Results Compared with group A,nerve cells were more obviously swelling,cytoplasm vacuoles area was increased,and the gap between cells was widened obviously,the expression level of LPA1 protein in rat cortex penumbra neurons was significantly higher in group B; compared with group C,the cerebral infarction area was significantly larger(P<0.05),nerve cells were more obviously swelling,cytoplasm vacuoles area was increased,and the gap between cells was widened obviously in the penumbra of group D; Western blotting and immunofluorescence showed that,compared with group C,the expression level of caspase-3 protein in the penumbra of group D was significantly increased(P<0.05),and the expression level of p-Akt protein was significantly decreased(P<0.05).Conclusion After administration of an LPA1 antagonist,the cerebral infarction area increased,brain tissue edema and neuronal apoptosis were more serious,the expression level of Caspase-3 protein increased in the penumbra,and the expression level of p-akt protein decreased,all above evidence conversely proved that LPA1 had a protective effect on ischemic neurons and it might play a protective role through the Akt pathway.

参考文献/References:

[1] Murray CJ,Lopez AD.Mortality by cause for eight regions of the world:Global Burden of Disease Study[J].Lancet,1997,349(961):1269-1276.
[2] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2014[J].中华神经科杂志,2015,48(4):246-257.
[3] Yung YC,Stoddard NC,Mirendil H,et al.Lysophosphatidic acid signaling in the nervous system[J].Neuron,2015,85(4):669-682.
[4] Frisca F,Sabbadini RA,Goldshmit Y,et al.Biological effects of lysophosphatidic acid in the nervous system[J].Int Rev Cell Mol Biol,2012,296:273-322.
[5] Dubin AE,Herr DR,Chun J.Diversity of lysophosphatidic acid receptor-mediated intracellular Calcium signaling in early cortical neurogenesis[J].J Neurosci,2010,30(21):7300-7309.
[6] Goldshmit Y,Munro K,Leong SY,et al.LPA receptor expression in the central nervous system in health and following injury[J].Cell Tissue Res,2010,341(1):23-32.
[7] Li ZG,Yu ZC,Wang DZ,et al.Influence of acetylsalicylate on plasma lysophosphatidic acid level in patients with ischemic cerebral vascular diseases[J].Neurol Res,2008,30(4):366-369.
[8] Cui MZ.Lysophosphatidic acid effects on atherosclerosis and thrombosis[J].Clin Lipidol,2011,6(4):413-426.
[9] Steiner MR,Holtsberg FW,Keller JN,et al.Lysophosphatidic acid induction of neuronal apoptosis and necrosis[J].Ann N Y Acad Sci,2000,905(1):132-141.
[10] Sorensen SD,Nicole O,Peavy RD,et al.Common signaling pathways Link activation of murine PAR-1,LPA,and S1P receptors to proliferation of astrocytes[J].Mol Pharmacol,2003,64(5):1199-1209.
[11] Shano S,Moriyama R,Chun J,et al.Lysophosphatidic acid stimulates astrocyte proliferation through LPA1[J].Neurochem Int,2008,52(1/2):216-220.
[12] Yu Y,Qin J,Liu M,et al.Role of Rho kinase in lysophosphatidic acid-induced altering of blood-brain barrier permeability[J].Int J Mol Med,2014,33(3):661-669.
[13] Longa EZ,Weinstein PR,Carlson S,et al.Reversible middle cerebral artery occlusion without craniectomy in rats[J].Stroke,1989,20(1):84-91.
[14] 韩俊伟,杜海燕.《大鼠脑立体定位图谱》出版消息[J].神经解剖学杂志,1991,1:118.
[15] 梁晓俐.病理学基础与实验技术[M].北京:军事医学科学出版社,2004:135-136.
[16] Bederson JB,Pitts LH,Germano SM,et al.Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification[J].Stroke,1986,17(6):1304-1308.
[17] 韩俊伟,杜海燕,河南畜牧兽医,等.病理学技术[M].北京:人民卫生出版社,2000:975.
[18] Thompson D,Larson G.Western blots using stained protein gels[J].Biotechniques,1992,12(5):656-658.
[19] Yung YC,Stoddard NC,Chun J.LPA receptor signaling:pharmacology,physiology,and pathophysiology[J].J Lipid Res,2014,55(7):1192-1214.
[20] Kihara Y,Maceyka M,Spiegel S,et al.Lysophospholipid receptor nomenclature review:IUPHAR Review 8[J].Br J Pharmacol,2014,171(15):3575-3594.
[21] Choi JW,Chun J.Lysophospholipids and their receptors in the central nervous system[J].Biochim Biophys Acta,2013,1831(1):20-32.
[22] Chun J,Hla T,Lynch KR,et al.International union of basic and clinical pharmacology.LXXVIII.lysophospholipid receptor nomenclature[J].Pharmacol Rev,2010,62(4):579-587.
[23] Savitz SI,Dhallu MS,Malhotra S,et al.EDG receptors as a potential therapeutic target in retinal ischemia-reperfusion injury[J].Brain Res,2006,1118(1):168-175.
[24] Yang C,Lafleur J,Mwaikambo BR,et al.The role of lysophosphatidic acid receptor(LPA1)in the oxygen-induced retinal ganglion cell degeneration[J].Invest Ophthalmol Vis Sci,2009,50(3):1290-1298.
[25] Herr KJ,Herr DR,Lee CW,et al.Stereotyped fetal brain disorganization is induced by hypoxia and requires lysophosphatidic acid receptor 1(LPA1)signaling[J].Proc Natl Acad Sci U S A,2011,108(37):15444-15449.
[26] Peter ME,Heufelder AE,Hengartner MO.Advances in apoptosis research[J].Proc Natl Acad Sci USA,1997,94(24):12736-12737.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助(项目批准号为81671051)
更新日期/Last Update: 2018-10-20